28 April 2020

Dr. Kongkrapan Intarajang, CEO of GC, together with his executive team, present CoviClear, or the silver nanoparticle disinfection unit to help reduce the risk of COVID-19 transmission to Chulalongkorn Hospital, the Thai Red Cross Society

Share:

Dr. Kongkrapan Intarajang, Chief Executive Officer of GC, and his executive team presented CoviClear or the silver nanoparticle disinfection unit, which is designed to help lower the risk of contracting COVID-19 along with raw materials in producing two types of disinfectant liquid namely; triethanolamine (TEA) for which GC is the only manufacturer in Thailand, and Pharmaceutical-grade glycerine for use in CoviClear to Chulalongkorn Hospital, the Thai Red Cross Society in which the donation was received by Prof. Dr. Suttipong Wacharasindhu, Dean of the Faculty of Medicine, Chulalongkorn University, Assoc. Prof. Dr. Chanchai Sittipunt, Associate Dean for Planning and Development Department, and Asst. Prof. Dr. Nakarin Sirisabya, Assistant Dean for Planning and Development Department, Faculty of Medicine, Chulalongkorn University.

CoviClear is an innovation developed by GC that increases the disinfection and prevention of germs by releasing silver nanoparticles through a micron-sized nozzle in the form of a vapor. The vapor pairs the silver nanoparticles with viruses, bacteria and other diseases which a person carries, including on their clothing, killing them on contact without causing any harm.

News

News
20 October 2021
GC Group strengthens Sustainable Growth for business and customers with “Together To Net Zero” Roadmap
Read More
News
25 April 2020
ThaiBev and GC present 1 million bottles of hand sanitizer gel for Village Health Volunteers [MGRonline]
Read More
News
15 September 2019
GC Rated Number One in the World for Sustainability in DJSI’s Chemicals Sector
Read More